<i>In Silico</i> Docking of Novel Phytoalkaloid Camalexin in the Management of Benomyl Induced Parkinson's Disease and its <i>In Vivo</i> Evaluation by Zebrafish Model.

Thamaraikani, Tamilanban; Karnam, Manasa; Velapandian, Chitra

In Silico Docking of Novel Phytoalkaloid Camalexin in the Management of Benomyl Induced Parkinson's Disease and its In Vivo Evaluation by Zebrafish Model.

Thamaraikani, Tamilanban; Karnam, Manasa; Velapandian, Chitra.

Afiliação

Thamaraikani T; Department of Pharmacology, SRM College of Pharmacy, SRMIST, Kattankulathur 603203, Tamilnadu, India.
Karnam M; Department of Pharmacology, SRM College of Pharmacy,SRMIST, Kattankulathur-603203,Tamilnadu, India.
Velapandian C; Department of Pharmacology, SRM College of Pharmacy,SRMIST, Kattankulathur-603203,Tamilnadu, India.

CNS Neurol Disord Drug Targets ; 21(4): 343-353, 2022.

Article em En | MEDLINE | ID: mdl-34477539

Assuntos

Aldeído Desidrogenase/metabolismo; Benomilo/metabolismo; Indóis/metabolismo; Doença de Parkinson/metabolismo; Tiazóis/metabolismo; Peixe-Zebra/metabolismo; Animais; Modelos Animais de Doenças; Dopamina/metabolismo

Palavras-chave

Alda-1; Autodock 4.2; Camalexin; Parkinson's disease; aldehyde dehydrogenase; benomyl

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Tiazóis / Benomilo / Peixe-Zebra / Aldeído Desidrogenase / Indóis Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google